EVALUATION OF THE EFFECT OF TOLVAPTAN ON OXIDATIVE STRESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

被引：0
|
作者：
Rigato, Matteo [1 ]
Bertoldi, Giovanni [1 ]
Ravarotto, Verdiana [1 ]
Carraro, Gianni [1 ]
Calo, Lorenzo [1 ]
机构：
[1] Univ Padua, Dept Med, Nephrol Dialysis & Transplantat Unit, Padua, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO022
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
    Pfeferman, Mariana Becker
    da Rocha, Daniel Ribeiro
    Rodrigues, Fernanda Guedes
    Pfeferman, Elcio
    Heilberg, Ita Pfeferman
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [32] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENT CHARACTERISTICS ASSOCIATED WITH BETTER RESPONSE TO TOLVAPTAN TREATMENT
    Gkika, Vasiliki
    Evangelou, Eirini
    Gkalitsiou, Dimitra
    Liaveri, Paraskevi
    Louka, Michaela
    Drakopoulos, Angelos
    Tigka, Eirini
    Vasileiou, Kyriaki
    Tsagkatakis, Mihail
    Tsirpanlis, George
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I235 - I236
  • [33] Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)
    Makabe, Shiho
    Mochizuki, Toshio
    Mitobe, Michihiro
    Aoyama, Yumi
    Kataoka, Hiroshi
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (05) : 1079 - 1087
  • [34] OPTIMIZATION OF THE EVALUATION OF TOTAL KIDNEY VOLUME IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Giulio, Del Vecchio
    Fenoglio, Roberta
    Roccatello, Dario
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [35] TOLVAPTAN TREATMENT FOR THREE YEARS SIGNIFICANTLY IMPROVED RENAL PROGNOSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS
    Gkika, Vasiliki
    Louka, Michaela
    Evangelou, Eirini
    Vasileiou, Kyriaki
    Gkalitsiou, Dimitra
    Kanellopoulou, Konstantina
    Drakopoulos, Angelos
    Tigka, Eirini
    Tsagkatakis, Mihail
    Tsirpanlis, George
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I226 - I227
  • [36] Identifying the main predictors of urine output in autosomal-dominant polycystic kidney disease (ADPKD) patients taking tolvaptan
    Francisco José Borrego Utiel
    Ana Isabel Morales García
    Aurora Polo Moyano
    Francisco Roca Oporto
    Enoc Merino García
    Rafael Esteban de la Rosa
    International Urology and Nephrology, 2023, 55 : 2629 - 2637
  • [37] Identifying the main predictors of urine output in autosomal-dominant polycystic kidney disease (ADPKD) patients taking tolvaptan
    Utiel, Francisco Jose Borrego
    Garcia, Ana Isabel Morales
    Moyano, Aurora Polo
    Oporto, Francisco Roca
    Garcia, Enoc Merino
    de la Rosa, Rafael Esteban
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (10) : 2629 - 2637
  • [38] Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)
    Shiho Makabe
    Toshio Mochizuki
    Michihiro Mitobe
    Yumi Aoyama
    Hiroshi Kataoka
    Ken Tsuchiya
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2018, 22 : 1079 - 1087
  • [39] SMALL TOTAL KIDNEY VOLUME IS COLLERATED WITH EFFECT OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS
    Kawashima, Keisuke
    Nishio, Saori
    Kondo, Keiichi
    Ishikawa, Yozo
    Hattanda, Fumihiko
    Makita, Minoru
    Kusunoki, Yoshihiro
    Matsuoka, Naoko
    Yamamoto, Junya
    Nakagaki, Tasuku
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 96 - 96
  • [40] Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
    Sans-Atxer, Laia
    Torra, Roser
    Fernandez-Llama, Patricia
    CLINICAL KIDNEY JOURNAL, 2013, 6 (05) : 457 - 463
12345